olfactory receptor family 5 subfamily BB member 1 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR5BB1P profile across patient tissues and cancer cell-line models. OR5BB1P expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, OR5BB1P is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, OR5BB1P RNA expression shows 4,455 significant gene co-expression associations, with the highest sampling consensus in THCA. Together, these results highlight UCEC, and THCA as cancer lineages where OR5BB1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR5BB1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR5BB1P survival associations across molecular data types. OR5BB1P RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR5BB1P RNA expression–survival associations across cancer types. High OR5BB1P expression shows unfavorable associations in UCEC, HNSC, SKCM, GBM, OV and PAAD. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for OR5BB1P RNA expression.
This table summarizes OR5BB1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for OR5BB1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR5BB1P shows higher tumor expression in THCA. The THCA box plot shows higher OR5BB1P RNA expression in tumor versus normal tissue (log2 FC = +0.166, t-test p < 0.001).
This table shows molecular features associated with OR5BB1P in patient tissues and cancer cell lines. In patient samples, OR5BB1P shows the broadest associations at the RNA and protein expression levels, with THCA recurring as the lineage with the largest associated feature set.
